This study is the first to explore synthetic miR-221/222 sponges as molecular therapy to re-sensitize tamoxifen-resistant breast cancer cells to the drug, and this effect may be based on the modulation of ERα and PTEN. Here, PTEN is linked to breast carcinoma.